StonvexLoading…
StonvexStonvexStonvexCore line items from DLO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.09B | $745.97M | $650.35M | $418.93M |
Operating Income | $219.91M | $140.50M | $179.66M | $127.91M |
Net Income | $196.90M | $120.47M | $149.09M | $108.70M |
EPS (Diluted) | $0.65 | $0.39 | $0.49 | $0.35 |
Total Assets | $1.54B | $1.17B | $1.08B | $826.30M |
Total Liabilities | $971.53M | $682.34M | $629.31M | $426.68M |
Cash & Equivalents | $719.90M | $425.17M | $536.16M | $468.09M |
Free Cash Flow OCF − CapEx | $413.18M | $-34.49M | $292.49M | $153.46M |
Shares Outstanding | Not available | Not available | Not available | Not available |